Work

Supplemental Figure S4 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

Year: 2026

Type: supplementary-materials

Abstract: The DNA-PKi enhancement of EWS cells sensitivity to etoposide DNA-PK inhibition is a class effect

DOI: 10.1158/1535-7163.32711206

Authors: Victor J. Collins, Katelyn R. Ludwig, Ariana E. Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh, Kristine A. Isanogle, Arnulfo Mendoza, Simone Difilippantonio, Baktiar O. Karim, Natasha J. Caplen, Christine M. Heske

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7164986288

Cites:

Cited by:

Related to: